AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33017854 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (GPT)
Number of subjects: 433
Study 33017854 — intervention group
Group type: COMPARATOR
Intervention: Clinical Management (CM)
Number of subjects: 433
Study 33170356 — intervention group
Group type: EXPERIMENTAL
Intervention: Creative advertisements
Number of subjects: 0
Study 33170356 — intervention group
Group type: EXPERIMENTAL
Intervention: Insight experience
Number of subjects: 0
Study 33170356 — intervention group
Group type: COMPARATOR
Intervention: Standard advertisements
Number of subjects: 0
Study 36482693 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver-only educational intervention with telephone follow-up
Number of subjects: 37
Study 32219638 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 49
Study 32219638 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 49
Study 33846088 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat acclimation (HOT) - 40 °C, 40% relative humidity, n = 16, 5 days of acclimation with exercise sessions
Number of subjects: 24
Study 33846088 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) - 23 °C, 25% relative humidity, n = 8
Number of subjects: 24
Study 36413049 — intervention group
Group type: EXPERIMENTAL
Intervention: 2gether intervention
Number of subjects: 685
Study 36413049 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 685
Study 34437784 — intervention group
Group type: EXPERIMENTAL
Intervention: elexacaftor-tezacaftor-ivacaftor
Number of subjects: 258
Study 34437784 — intervention group
Group type: COMPARATOR
Intervention: active control
Number of subjects: 258
Study 33264200 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS intervention (n = 30)
Number of subjects: 60
Study 33264200 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU) group (n = 30)
Number of subjects: 60
Study 35793883 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical rehabilitation plus flexibility training
Number of subjects: 30
Study 35793883 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexibility training
Number of subjects: 30
Study 35793883 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 33823924 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB) with 0.375% ropivacaine 0.4 ml/kg
Number of subjects: 166
Study 33823924 — intervention group
Group type: COMPARATOR
Intervention: Thoracic paravertebral block (TPVB) with 0.375% ropivacaine 0.4 ml/kg
Number of subjects: 166
Study 33823924 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Number of subjects: 166
Study 33823924 — intervention group
Group type: COMPARATOR
Intervention: Thoracic paravertebral block (TPVB)
Number of subjects: 166
Study 35817286 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg/day)
Number of subjects: 143
Study 35817286 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone (60 mg/day in two divided doses)
Number of subjects: 143
Study 33401397 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous cycling ergometer (55% VO2max)
Number of subjects: 60
Study 33401397 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity strength program
Number of subjects: 60
Study 33401397 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity physical activity program
Number of subjects: 60
Study 32272777 — intervention group
Group type: EXPERIMENTAL
Intervention: LF-containing yogurt (100 mg/day)
Number of subjects: 1296
Study 32272777 — intervention group
Group type: COMPARATOR
Intervention: Control group (fruit jelly)
Number of subjects: 1296
Study 33243964 — intervention group
Group type: EXPERIMENTAL
Intervention: Red noise
Number of subjects: 22
Study 33243964 — intervention group
Group type: EXPERIMENTAL
Intervention: Pink noise
Number of subjects: 22
Study 33243964 — intervention group
Group type: EXPERIMENTAL
Intervention: White noise
Number of subjects: 22
Study 33243964 — intervention group
Group type: EXPERIMENTAL
Intervention: Red and pink noise
Number of subjects: 22
Study 36316797 — intervention group
Group type: EXPERIMENTAL
Intervention: Descemet Membrane Endothelial Keratoplasty (DMEK)
Number of subjects: 53
Study 36316797 — intervention group
Group type: COMPARATOR
Intervention: Ultrathin Descemet Stripping Automated Endothelial Keratoplasty (UT-DSAEK)
Number of subjects: 53
Study 33876660 — intervention group
Group type: EXPERIMENTAL
Intervention: Song of Life music therapy intervention
Number of subjects: 104
Study 33876660 — intervention group
Group type: COMPARATOR
Intervention: Relaxation intervention (control group)
Number of subjects: 104
Study 36494503 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 60
Study 36494503 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 60
Study 34225757 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 or 2 HEPA filter air cleaners
Number of subjects: 478
Study 34225757 — intervention group
Group type: COMPARATOR
Intervention: No air cleaners (Control)
Number of subjects: 478
Study 34225757 — intervention group
Group type: EXPERIMENTAL
Intervention: First trimester PM2.5 concentration increase (20.1 µg/m3)
Number of subjects: 478
Study 34225757 — intervention group
Group type: EXPERIMENTAL
Intervention: Third trimester PM2.5 concentrations
Number of subjects: 478
Study 34225757 — intervention group
Group type: EXPERIMENTAL
Intervention: Second trimester PM2.5 concentrations
Number of subjects: 478
Study 33120779 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone assistance nursing program (extra coaching sessions on self-care, exercise guidance)
Number of subjects: 90
Study 33120779 — intervention group
Group type: COMPARATOR
Intervention: Standard management (control group, exercises at home not monitored)
Number of subjects: 90
Study 35622060 — intervention group
Group type: EXPERIMENTAL
Intervention: PR/RP+SIM/methylcellulose (MCL); n = 27
Number of subjects: 50
Study 35622060 — intervention group
Group type: COMPARATOR
Intervention: PR/RP+methylcellulose (MCL); n = 23
Number of subjects: 50
Study 35622060 — intervention group
Group type: EXPERIMENTAL
Intervention: PR/RP+SIM/methylcellulose (MCL)
Number of subjects: 50
Study 35622060 — intervention group
Group type: COMPARATOR
Intervention: PR/RP+methylcellulose (MCL)
Number of subjects: 50
Study 33136069 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous heart rate characteristics (HRC) monitoring
Number of subjects: 823
Study 33136069 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics after UTI
Number of subjects: 823
Study 33136069 — intervention group
Group type: COMPARATOR
Intervention: No uroprophylaxis after first UTI
Number of subjects: 823
Study 33136069 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal ultrasounds (RUS) after UTI
Number of subjects: 823
Study 33136069 — intervention group
Group type: EXPERIMENTAL
Intervention: Voiding cystourethrograms (VCUG)
Number of subjects: 823
Study 32897665 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical muscle stimulation
Number of subjects: 42
Study 32897665 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 42
Study 36266337 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated host-microbe plasma metagenomics
Number of subjects: 221
Study 36266337 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma RNA transcriptional signature
Number of subjects: 221
Study 36266337 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary transcriptomic classifier for virus detection
Number of subjects: 221
Study 36266337 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated sepsis diagnostic model
Number of subjects: 221
Study 34491026 — intervention group
Group type: EXPERIMENTAL
Intervention: HARC
Number of subjects: 210
Study 34491026 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 210
Study 36250415 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Sleeve Gastrectomy (LSG)
Number of subjects: 0
Study 36250415 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux‐En‐Y Gastric Bypass (RYGB)
Number of subjects: 0
Study 36250415 — intervention group
Group type: COMPARATOR
Intervention: Immediate TKR
Number of subjects: 0
Study 36250415 — intervention group
Group type: COMPARATOR
Intervention: No weight loss/no TKR
Number of subjects: 0
Study 35924869 — intervention group
Group type: EXPERIMENTAL
Intervention: STRIDE (telehealth intervention)
Number of subjects: 100
Study 35924869 — intervention group
Group type: COMPARATOR
Intervention: MedMon (medication monitoring control)
Number of subjects: 100
Study 32725244 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise approach including 6-month lifestyle modification curriculum plus metformin
Number of subjects: 578
Study 32725244 — intervention group
Group type: COMPARATOR
Intervention: Standard lifestyle advice
Number of subjects: 578
Study 33180913 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Coach Jr. intervention (educational materials and three individual phone calls); N = 20
Number of subjects: 39
Study 33180913 — intervention group
Group type: COMPARATOR
Intervention: Standard Care condition; N = 19
Number of subjects: 39
Study 36501086 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric Carboxymaltose (FCM) 500 mg IV infusion, given at time 0 and repeated after 4 weeks
Number of subjects: 64
Study 36501086 — intervention group
Group type: COMPARATOR
Intervention: Placebo (100 mL of saline given i.v. in 10 min), n = 32
Number of subjects: 64
Study 32232540 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral cerebellar rTMS (10 Hz)
Number of subjects: 13
Study 32232540 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral cerebellar rTMS (10 Hz)
Number of subjects: 13
Study 35850873 — intervention group
Group type: EXPERIMENTAL
Intervention: Airborne-particle abrasion (APA)
Number of subjects: 169
Study 35850873 — intervention group
Group type: EXPERIMENTAL
Intervention: Tribochemical silica airborne-particle abrasion (TS)
Number of subjects: 169
Study 35850873 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonthermal oxygen plasma (NTP)
Number of subjects: 169
Study 35850873 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 169
Study 34836336 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooked coix seed (160 g per day) for 7 days
Number of subjects: 19
Study 33966521 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic adjustment algorithm (DAA) with telephone follow-ups for 30 days
Number of subjects: 206
Study 33966521 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic adjustment algorithm (DAA)
Number of subjects: 206
Study 33966521 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - diuretic dose adjusted by physician at baseline only
Number of subjects: 206
Study 33051975 — intervention group
Group type: EXPERIMENTAL
Intervention: Tripeptide/hexapeptide serum
Number of subjects: 20
Study 33051975 — intervention group
Group type: COMPARATOR
Intervention: Bland moisturizer
Number of subjects: 20
Study 36268587 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacral massage
Number of subjects: 220
Study 34287817 — intervention group
Group type: EXPERIMENTAL
Intervention: rTPJ anodal high-definition transcranial direct current stimulation
Number of subjects: 52
Study 34287817 — intervention group
Group type: EXPERIMENTAL
Intervention: dmPFC anodal high-definition transcranial direct current stimulation
Number of subjects: 52
Study 34287817 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 52
Study 32846573 — intervention group
Group type: EXPERIMENTAL
Intervention: Mango juice by-product (JBP) beverage (0.04 g·ml-1)
Number of subjects: 100
Study 32846573 — intervention group
Group type: COMPARATOR
Intervention: Flavored water (control group)
Number of subjects: 100
Study 36501091 — intervention group
Group type: EXPERIMENTAL
Intervention: High-nutrient-quality diet
Number of subjects: 110
Study 36501091 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-nutrient-quality diet
Number of subjects: 110
Study 36501091 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 110
Study 36501091 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline postprandial FGF21 response
Number of subjects: 110
Study 36501091 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher habitual polysaccharide intake
Number of subjects: 110
Study 34674670 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ibuprofen 10 mg/kg
Number of subjects: 40
Study 34674670 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 40
Study 32353739 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized SVD (rSVD) clutter filtering with a downsampling factor of 12 and 12 threads on a 12-core CPU.
Number of subjects: 0
Study 32353739 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized SVD (rSVD) clutter filtering with a block size of 20x20 pixels, ensemble size 45, and rank of tissue clutter subspace 26.
Number of subjects: 0
Study 34881942 — intervention group
Group type: EXPERIMENTAL
Intervention: Jungian psychotherapy (JP) with a focus on spirituality and synchronicity
Number of subjects: 0
Study 32173020 — intervention group
Group type: EXPERIMENTAL
Intervention: Canal preparation using Protaper Next files until size X3
Number of subjects: 18
Study 32173020 — intervention group
Group type: COMPARATOR
Intervention: Canal preparation using Protaper Next files until size X5
Number of subjects: 18
Study 32173020 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (X3 and X5)
Number of subjects: 18
Study 33706602 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically indicated replacement
Number of subjects: 600
Study 33706602 — intervention group
Group type: COMPARATOR
Intervention: Routine replacement
Number of subjects: 600
Study 34073610 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 g daily of bitter and strong-tasting (BST) vegetables
Number of subjects: 92
Study 34073610 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 g daily of mild and sweet-tasting (MST) vegetables
Number of subjects: 92
Study 34073610 — intervention group
Group type: COMPARATOR
Intervention: 120 g daily MST normal diet (control)
Number of subjects: 92
Study 36113110 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsupervised physical activity (30 min of self-administered physical aerobic activity daily for 2 weeks before and 4 weeks after surgery)
Number of subjects: 354
Study 36113110 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsupervised physical activity
Number of subjects: 354
Study 36113110 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemotherapy subgroup
Number of subjects: 354
Study 33963058 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole blood donation every 12 weeks
Number of subjects: 0
Study 33963058 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma donation every 6 weeks
Number of subjects: 0
Study 33963058 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32314505 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.4 mg/kg GLP-1-gFc
Number of subjects: 0
Study 32314505 — intervention group
Group type: COMPARATOR
Intervention: 0.6 mg/kg dulaglutide
Number of subjects: 0
Study 32314505 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.28 mg/kg GLP-1-gFc
Number of subjects: 0
Study 32314505 — intervention group
Group type: COMPARATOR
Intervention: 0.07 mg/kg dulaglutide
Number of subjects: 0
Study 32314505 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1-gFc
Number of subjects: 0
Study 32314505 — intervention group
Group type: COMPARATOR
Intervention: dulaglutide
Number of subjects: 0
Study 35449803 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training rehabilitation for 26 weeks
Number of subjects: 0
Study 35449803 — intervention group
Group type: COMPARATOR
Intervention: Control group (no aerobic exercise training)
Number of subjects: 0
Study 35449803 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training rehabilitation
Number of subjects: 0
Study 33148771 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visiting
Number of subjects: 1449
Study 33148771 — intervention group
Group type: EXPERIMENTAL
Intervention: Group sessions
Number of subjects: 1449
Study 33148771 — intervention group
Group type: COMPARATOR
Intervention: Nutritional education
Number of subjects: 1449
Study 34303223 — intervention group
Group type: EXPERIMENTAL
Intervention: High-closeness discussion
Number of subjects: 105
Study 34303223 — intervention group
Group type: COMPARATOR
Intervention: Low-closeness discussion
Number of subjects: 105
Study 32584613 — intervention group
Group type: EXPERIMENTAL
Intervention: Young patient cohort (aged 18 to 40)
Number of subjects: 59
Study 35039192 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Focused Ultrasound Ablation (HIFUA)
Number of subjects: 42
Study 32648641 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanut protein ingestion (300-1000 mg)
Number of subjects: 20
Study 32404169 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloe vera 3% topical ointment
Number of subjects: 42
Study 36305561 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher power short duration (HPSD) ablation at 40 W
Number of subjects: 88
Study 36305561 — intervention group
Group type: COMPARATOR
Intervention: Lower power longer duration (LPLD) ablation at 25 W
Number of subjects: 88
Study 36305561 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher power short duration (HPSD) ablation
Number of subjects: 88
Study 36305561 — intervention group
Group type: COMPARATOR
Intervention: Lower power longer duration (LPLD) ablation
Number of subjects: 88
Study 34348775 — intervention group
Group type: EXPERIMENTAL
Intervention: 38% Silver Diamine Fluoride (SDF)
Number of subjects: 688
Study 34348775 — intervention group
Group type: COMPARATOR
Intervention: 5% Sodium Fluoride (NaF) varnish
Number of subjects: 688
Study 34392814 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoiding screen use in bed
Number of subjects: 30
Study 34392814 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoiding caffeine, alcohol and cigarettes before bedtime
Number of subjects: 30
Study 34392814 — intervention group
Group type: EXPERIMENTAL
Intervention: Having a regular bedtime and wake up time even on weekends
Number of subjects: 30
Study 32512259 — intervention group
Group type: EXPERIMENTAL
Intervention: Ancient samples (C-shaped root canals)
Number of subjects: 38
Study 32512259 — intervention group
Group type: COMPARATOR
Intervention: Control group (modern samples)
Number of subjects: 38
Study 32512259 — intervention group
Group type: EXPERIMENTAL
Intervention: Ancient samples (C-shaped canals classification)
Number of subjects: 38
Study 32512259 — intervention group
Group type: EXPERIMENTAL
Intervention: Ancient samples (fused root and groove types)
Number of subjects: 38
Study 35569763 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-mg intravitreal risuteganib injection
Number of subjects: 39
Study 32973056 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printed models (3DP)
Number of subjects: 153
Study 32973056 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality models (VR)
Number of subjects: 153
Study 32973056 — intervention group
Group type: COMPARATOR
Intervention: Normal physical models (NP)
Number of subjects: 153
Study 34419209 — intervention group
Group type: EXPERIMENTAL
Intervention: L3-700 (50 L3 larvae, UVC-attenuated)
Number of subjects: 22
Study 34419209 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Tabasco sauce)
Number of subjects: 22
Study 32819441 — intervention group
Group type: EXPERIMENTAL
Intervention: Ear acupressure (Vaccaria seed)
Number of subjects: 76
Study 32819441 — intervention group
Group type: COMPARATOR
Intervention: Sham control (non-latex-based adhesives with no Vaccaria seeds)
Number of subjects: 76
Study 35387826 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injection
Number of subjects: 0
Study 35387826 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 0
Study 34202762 — intervention group
Group type: EXPERIMENTAL
Intervention: High cognitive exertion
Number of subjects: 10
Study 34202762 — intervention group
Group type: COMPARATOR
Intervention: Low cognitive exertion
Number of subjects: 10
Study 32708396 — intervention group
Group type: COMPARATOR
Intervention: 2×/week aerobic and resistance training only (EX)
Number of subjects: 134
Study 32708396 — intervention group
Group type: EXPERIMENTAL
Intervention: exercise routine combined with dietary counseling (EXDC)
Number of subjects: 134
Study 32708396 — intervention group
Group type: EXPERIMENTAL
Intervention: exercise routine combined with intake of 2 g/day oil from Calanus finmarchicus (EXCO)
Number of subjects: 134
Study 35124144 — intervention group
Group type: EXPERIMENTAL
Intervention: Isopropanol-based (Hopigel®)
Number of subjects: 38
Study 35124144 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol-based (WHO gel formulation)
Number of subjects: 38
Study 35124144 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol-based with superfatting agents (Saniswiss Sanitizer Hands H1)
Number of subjects: 38
Study 34265787 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain E‐Consult Program (PEP)
Number of subjects: 665
Study 34265787 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 665
Study 35177467 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT) intervention, prescribed at 90%-95% of peak heart rate for 12 weeks
Number of subjects: 60
Study 35177467 — intervention group
Group type: COMPARATOR
Intervention: Standard care (relevant lifestyle advice and cardio‐preventive medication)
Number of subjects: 60
Study 34517392 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified upward laryngeal handshake technique
Number of subjects: 198
Study 34517392 — intervention group
Group type: COMPARATOR
Intervention: Conventional downward laryngeal handshake technique
Number of subjects: 198
Study 32521284 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration therapy (10 self-applied sessions)
Number of subjects: 28
Study 32521284 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28
Study 35793181 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector Spinae Block (ESB)
Number of subjects: 63
Study 35793181 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal Block (CB)
Number of subjects: 63
Study 35793181 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 63
Study 34960106 — intervention group
Group type: COMPARATOR
Intervention: Liposomal formulation of vitamin A
Number of subjects: 75